MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 28, 2006; DOI: 10.1124/mol.105.021691


0026-895X/06/7001-214-226$20.00
Mol Pharmacol 70:214-226, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021691v1
70/1/214    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halls, M. L.
Right arrow Articles by Summers, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halls, M. L.
Right arrow Articles by Summers, R. J.

Relaxin Family Peptide Receptors RXFP1 and RXFP2 Modulate cAMP Signaling by Distinct Mechanisms

Michelle L. Halls, Ross A. D. Bathgate, and Roger J. Summers

Department of Pharmacology, Monash University, Clayton, Australia (M.L.H., R.J.S.); and Howard Florey Institute, Melbourne, Australia (R.A.D.B.)

Two orphan leucine-rich repeat-containing G protein-coupled receptors were recently identified as targets for the relaxin family peptides relaxin and insulin-like peptide (INSL) 3. Human gene 2 relaxin is the cognate ligand for relaxin family peptide receptor (RXFP) 1, whereas INSL3 is the ligand for RXFP2. Constitutively active mutants of both receptors when expressed in human embryonic kidney (HEK) 293T cells signal through G{alpha}s to increase cAMP. However, recent studies using cells that endogenously express the receptors revealed greater complexity: cAMP accumulation after activation of RXFP1 involves a time-dependent biphasic pathway with a delayed phase involving phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) {zeta}, whereas the RXFP2 response involves inhibition of adenylate cyclase via pertussis toxin-sensitive G proteins. The aim of this study was to compare and contrast the cAMP signaling pathways used by these two related receptors. In HEK293T cells stably transfected with RXFP1, preliminary studies confirmed the biphasic cAMP response, with an initial G{alpha}s component and a delayed response involving PI3K and PKC{zeta}. This delayed pathway was dependent upon G-beta{gamma} subunits derived from G{alpha}i3. An additional inhibitory pathway involving G{alpha}oB affecting cAMP accumulation was also identified. In HEK293T cells stably transfected with RXFP2, the cAMP response involved G{alpha}s and was modulated by inhibition mediated by G{alpha}oB and release of inhibitory G-beta{gamma} subunits. Thus, initially both RXFP1 and RXFP2 couple to G{alpha}s and an inhibitory G{alpha}oB pathway. Differences in cAMP accumulation stem from the ability of RXFP1 to recruit coupling to G{alpha}i3, release G-beta{gamma} subunits and thus activate a delayed PI3K-PKC{zeta} pathway to further increase cAMP accumulation.


Received December 14, 2005; accepted March 28, 2006

Address correspondence to: Prof. Roger J. Summers, Department of Pharmacology, P.O. Box 13E, Monash University, Clayton, VIC 3800, Australia. E-mail: roger.summers{at}med.monash.edu.au




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
K. Heng, R. Ivell, P. Wagaarachchi, and R. Anand-Ivell
Relaxin signalling in primary cultures of human myometrial cells
Mol. Hum. Reprod., October 1, 2008; 14(10): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker
Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X.-l. Moore, S.-l. Tan, C.-y. Lo, L. Fang, Y.-D. Su, X.-M. Gao, E. A. Woodcock, R. J. Summers, G. W. Tregear, R. A. D. Bathgate, et al.
Relaxin Antagonizes Hypertrophy and Apoptosis in Neonatal Rat Cardiomyocytes
Endocrinology, April 1, 2007; 148(4): 1582 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. L. Halls, R. A. D. Bathgate, and R. J. Summers
Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 281 - 290.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics